Author Correction: Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice

Raffaella Rossin; Ron M Versteegen; Jeremy Wu; Alisher Khasanov; Hans J Wessels; Erik J Steenbergen; Wolter Ten Hoeve; Henk M Janssen; Arthur H A M van Onzen; Peter J Hudson; Marc S Robillard

doi:10.1038/s41467-019-08376-x

Author Correction: Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice

Nat Commun. 2019 Jan 16;10(1):363. doi: 10.1038/s41467-019-08376-x.

Affiliations

¹ Tagworks Pharmaceuticals, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.
² SyMO-Chem B.V., Den Dolech 2, 5612 AZ, Eindhoven, The Netherlands.
³ Avipep Pty Ltd, 343 Royal Parade, Parkville, VIC, 3052, Australia.
⁴ Levena Biopharma, 4955 Directors Place, Suite 300, San Diego, CA, 92121, USA.
⁵ Radboud Proteomics Centre, Department of Laboratory Medicine, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
⁶ Department of Pathology, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
⁷ Syncom B.V., Kadijk 3, 9747 AT, Groningen, The Netherlands.
⁸ Tagworks Pharmaceuticals, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands. marc.robillard@tagworkspharma.com.

Abstract

The original version of this Article omitted the following from the Acknowledgements: 'This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Breast Cancer Research Program under Award No. W81XWH-15-1-0692. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense'. This error has now been corrected in the PDF and HTML versions of the Article.

Publication types

Published Erratum